Programmed cell death in gouty nephropathy: molecular mechanisms and therapeutic implications - Takeaways - MDSpire

Programmed cell death in gouty nephropathy: molecular mechanisms and therapeutic implications

  • By

  • Shengyi Zhao

  • Bingbing Chen

  • He Qian

  • Rong Wang

  • Sanjin Zeng

  • Heguo Yan

  • Jian Zhang

  • Zhaohu Xie

  • Zhaofu Li

  • May 25, 2026

  • 0 min

Share

  • 1

    Gouty nephropathy is driven by persistent hyperuricemia, leading to programmed cell death and renal functional decline.

  • 2

    Multiple forms of programmed cell death, including apoptosis and necroptosis, are activated in gouty nephropathy, contributing to tubular injury.

  • 3

    The interplay of programmed cell death pathways forms a network that exacerbates inflammation and renal damage in gouty nephropathy.

  • 4

    Targeting key nodes of the programmed cell death network offers new therapeutic strategies beyond conventional urate-lowering treatments.

  • 5

    Understanding the molecular mechanisms of programmed cell death in gouty nephropathy reveals novel opportunities for kidney protection.

Original Source(s)

Programmed cell death in gouty nephropathy: molecular mechanisms and therapeutic implications

  • by Shengyi Zhao, Bingbing Chen, He Qian, Rong Wang, Sanjin Zeng, Heguo Yan, Jian Zhang, Zhaohu Xie, Zhaofu Li

  • May 25, 2026

Related Content

Clinical, functional, and immunological profiles across frailty subgroups in maintenance hemodialysis patient

Artificial intelligence-based quantification of retinal microvascular biomarkers from fundus photography of chronic kidney disease: a case-control study

Plasma PZP level elevation: a potential correlate of diabetic kidney disease progression